A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 21, 2017

Primary Completion Date

July 7, 2017

Study Completion Date

July 7, 2017

Conditions
Sunscreening Agents
Interventions
OTHER

NGBUV000A, (Expected SPF 30)

A total of 2.0 ± 0.05 mg/cm2 (milligram per centimeter square of test site area) NGBUV000A (test product 1) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 1 will be applied to the test plates.

OTHER

NGBUV000B, (Expected SPF 30)

A total of 2.0 ± 0.05 mg/cm2 NGBUV000B (test product 2) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 2 will be applied to the test plates.

OTHER

NGBUV000C, (Expected SPF 30)

A total of 2.0 ± 0.05 mg/cm2 NGBUV000C (test product 3) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 3 will be applied to the test plates.

OTHER

NGBUV000D, (Expected SPF 30)

A total of 2.0 ± 0.05 mg/cm2 NGBUV000D (test product 4) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 4 will be applied to the test plates.

OTHER

P3 Standard, (Expected SPF 16)

A total of 2.0 ± 0.05 mg/cm2 reference P3 standard will be spread at the topical test sites on the back of each participant.

OTHER

Sunscreen formulation S2

A total of 1.3 mg/cm2 of sunscreen formulation S2 will be applied to the test plates.

OTHER

Glycerin

A total of 1.3 mg/cm2 of glycerin will be applied to the test plates.

Trial Locations (1)

22869

GSK Investigational Site, Schenefeld

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY